Scientific Publications

Most Recent Publications

Treg-specific CD226 Deletion Reduces Diabetes Incidence in NOD Mice by Improving Regulatory T Cell Stability

Thirawatananond P, Brown ME, Sachs LK, Arnoletti JM, Yeh WI, Posgai AL, Shapiro MR, Chen YG, Brusko TM. Diabetes. 2023 Aug 25:db230307. doi: 10.2337/db23-0307. PMID: 37625150.

Human Immune Phenotyping Reveals Accelerated Aging in Type 1 Diabetes.

Shapiro MR, Dong X, Perry DJ, McNichols JM, Thirawatananond P, Posgai AL, Peters LD, Motwani K, Musca RS, Muir A, Concannon P, Jacobsen LM, Mathews CE, Wasserfall CH, Haller MJ, Schatz DA, Atkinson MA, Brusko MA, Bacher R, Brusko TM. JCI Insight. 2023 Sep 8;8(17):e170767. doi: 10.1172/jci.insight.170767. PMID: 37498686.

Exocrine Pancreas Dysfunction in Type 1 Diabetes.

Foster TP, Bruggeman B, Campbell-Thompson M, Atkinson MA, Haller MJ, Schatz DA. Endocr Pract. 2020 Dec;26(12):1505-1513. doi: 10.4158/EP-2020-0295. PMID: 33471743.

Longitudinal Trends in Glycemic Outcomes and Technology Use for Over 48,000 People with Type 1 Diabetes (2016-2022) from the T1D Exchange Quality Improvement Collaborative.

Ebekozien O, Mungmode A, Sanchez J, Rompicherla S, Demeterco-Berggren C, Weinstock RS, Jacobsen LM, Davis G, McKee A, Akturk HK, Maahs DM, Kamboj MK. Diabetes Technol Ther. 2023 Nov;25(11):765-773. doi: 10.1089/dia.2023.0320. PMID: 37768677

Development of a Short Form of the State Anxiety Inventory for Children.

Driscoll KA, Melin J, Lynch K, Smith L, Johnson SB. SAI-CH-6: Journal of Pediatric Psychology. 2023 Oct 20;48(10):861-869. doi: 10.1093/jpepsy/jsad057. PMID: 37698990

Type 1 Diabetes Continuous Glucose Monitoring Use in the Pediatric Emergency Department Affects Laboratory Test Frequency but Not Treatment Timing. 

Baker RK, Filipp SL, Jacobsen LM. Diabetes Spectr. 2023 Summer;36(3):275-280. doi: 10.2337/ds22-0061. PMID: 37583555

Time for Changes in Type 1 Diabetes Intervention Trial Designs.

Atkinson MA, Haller MJ, Schatz DA, Battaglia M, Mathieu C. Lancet Diabetes Endocrinol. 2023 Nov;11(11):789-791. doi: 10.1016/S2213-8587(23)00262-0. PMID: 37802093.

The Pathogenic “Symphony” in Type 1 Diabetes: A Disorder of the Immune System, β Cells, and Exocrine Pancreas.

Atkinson MA, Mirmira RG. Cell Metab. 2023 Sep 5;35(9):1500-1518. doi: 10.1016/j.cmet.2023.06.018. PMID: 37478842.

Post-Transplant Diabetes Mellitus: Recent Developments in Pharmacological Management of Hyperglycemia.

Munoz Pena JM, Cusi K.J Clin Endocrinol Metab. 2023 Jul 6:dgad395. doi: 10.1210/clinem/dgad395. Online ahead of print.PMID: 37410930 2

Site-specific development and progressive maturation of human tissue-resident memory T cells over infancy and childhood.

Connors TJ, Matsumoto R, Verma S, Szabo PA, Guyer R, Gray J, Wang Z, Thapa P, Dogra P, Poon MML, Rybkina K, Bradley MC, Idzikowski E, McNichols J, Kubota M, Pethe K, Shen Y, Atkinson MA, Brusko M, Brusko TM, Yates AJ, Sims PA, Farber DL.Immunity. 2023 Jul 4:S1074-7613(23)00265-0. doi: 10.1016/j.immuni.2023.06.008. Online ahead of print.PMID: 37421943 3

Identification of High Risk NAFLD Patients in Endocrinology Clinics.

Younossi ZM, Henry L, Isaacs S, Cusi K.Endocr Pract. 2023 Jul 3:S1530-891X(23)00469-X. doi: 10.1016/j.eprac.2023.06.012. Online ahead of print.PMID: 37406857Review. 4

Blue Circle Health: A Novel Patient-Centered Model of Health Care Delivery for Low-Income Patients With Type 1 Diabetes.

Bruggeman BS, Walker AF, Peters AL, D’Avolio LW, Haller MJ.J Diabetes Sci Technol. 2023 Jul;17(4):925-934. doi: 10.1177/19322968221149008. Epub 2023 Jan 29.PMID: 36710449 5

Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States.

Golabi P, Paik JM, Kumar A, Al Shabeeb R, Eberly KE, Cusi K, GunduRao N, Younossi ZM.Metabolism. 2023 Jun 26;146:155642. doi: 10.1016/j.metabol.2023.155642. Online ahead of print.PMID: 37380016 6

Nano-Targeted Delivery of Immune Therapeutics in type 1 Diabetes.

Jung S, Nasr MB, Bahmani B, Usuelli V, Zhao J, Sabiu G, Seelam AJ, Naini SM, Balasubramanian HB, Park Y, Li X, Khalefa SA, Kasinath V, Williams MD, Rachid O, Haik Y, Tsokos GC, Wasserfall CH, Atkinson MA, Bromberg JS, Tao W, Fiorina P, Abdi R.Adv Mater. 2023 Jun 26:e2300812. doi: 10.1002/adma.202300812. Online ahead of print.PMID: 37357903 7

A multi-society Delphi consensus statement on new fatty liver disease nomenclature.

Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, Arrese M, Bataller R, Beuers U, Boursier J, Bugianesi E, Byrne C, Castro Narro GE, Chowdhury A, Cortez-Pinto H, Cryer D, Cusi K, El-Kassas M, Klein S, Eskridge W, Fan J, Gawrieh S, Guy CD, Harrison SA, Kim SU, Koot B, Korenjak M, Kowdley K, Lacaille F, Loomba R, Mitchell-Thain R, Morgan TR, Powell E, Roden M, Romero-Gómez M, Silva M, Singh SP, Sookoian SC, Spearman CW, Tiniakos D, Valenti L, Vos MB, Wong VW, Xanthakos S, Yilmaz Y, Younossi Z, Hobbs A, Villota-Rivas M, Newsome PN; NAFLD Nomenclature consensus group.Hepatology. 2023 Jun 24. doi: 10.1097/HEP.0000000000000520. Online ahead of print.PMID: 37363821 8

Interventions to address global inequity in diabetes: international progress.

Walker AF, Graham S, Maple-Brown L, Egede LE, Campbell JA, Walker RJ, Wade AN, Mbanya JC, Long JA, Yajnik C, Thomas N, Ebekozien O, Odugbesan O, DiMeglio LA, Agarwal S.Lancet. 2023 Jun 22:S0140-6736(23)00914-5. doi: 10.1016/S0140-6736(23)00914-5. Online ahead of print.PMID: 37356448Review. 9

A multi-society Delphi consensus statement on new fatty liver disease nomenclature.

Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, Arrese M, Bataller R, Beuers U, Boursier J, Bugianesi E, Byrne C, Narro GEC, Chowdhury A, Cortez-Pinto H, Cryer D, Cusi K, El-Kassas M, Klein S, Eskridge W, Fan J, Gawrieh S, Guy CD, Harrison SA, Kim SU, Koot B, Korenjak M, Kowdley K, Lacaille F, Loomba R, Mitchell-Thain R, Morgan TR, Powell E, Roden M, Romero-Gómez M, Silva M, Singh SP, Sookoian SC, Spearman CW, Tiniakos D, Valenti L, Vos MB, Wong VW, Xanthakos S, Yilmaz Y, Younossi Z, Hobbs A, Villota-Rivas M, Newsome PN (senior); NAFLD Nomenclature consensus group.Ann Hepatol. 2023 Jun 20:101133. doi: 10.1016/j.aohep.2023.101133. Online ahead of print.PMID: 37364816Free article.Review. 10

A multi-society Delphi consensus statement on new fatty liver disease nomenclature.

Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, Arrese M, Bataller R, Beuers U, Boursier J, Bugianesi E, Byrne C, Castro Narro GE, Chowdhury A, Cortez-Pinto H, Cryer D, Cusi K, El-Kassas M, Klein S, Eskridge W, Fan J, Gawrieh S, Guy CD, Harrison SA, Kim SU, Koot B, Korenjak M, Kowdley K, Lacaille F, Loomba R, Mitchell-Thain R, Morgan TR, Powell E, Roden M, Romero-Gómez M, Silva M, Singh SP, Sookoian SC, Spearman CW, Tiniakos D, Valenti L, Vos MB, Wai-Sun Wong V, Xanthakos S, Yilmaz Y, Younossi Z, Hobbs A, Villota-Rivas M, Newsome PN; NAFLD Nomenclature consensus group.J Hepatol. 2023 Jun 20:S0168-8278(23)00418-X. doi: 10.1016/j.jhep.2023.06.003. Online ahead of print.PMID: 37364790Free article.Review. 11

A global research priority agenda to advance public health responses to fatty liver disease.

Lazarus JV, Mark HE, Allen AM, Arab JP, Carrieri P, Noureddin M, Alazawi W, Alkhouri N, Alqahtani SA, Arrese M, Bataller R, Berg T, Brennan PN, Burra P, Castro-Narro GE, Cortez-Pinto H, Cusi K, Dedes N, Duseja A, Francque SM, Hagström H, Huang TT, Wajcman DI, Kautz A, Kopka CJ, Krag A, Miller V, Newsome PN, Rinella ME, Romero D, Sarin SK, Silva M, Spearman CW, Tsochatzis EA, Valenti L, Villota-Rivas M, Zelber-Sagi S, Schattenberg JM, Wong VW, Younossi ZM; Healthy Livers, Healthy Lives Collaborators.J Hepatol. 2023 Jun 20:S0168-8278(23)00323-9. doi: 10.1016/j.jhep.2023.04.035. Online ahead of print.PMID: 37353401Free article. 12

A randomized controlled clinical trial to improve health outcomes in youth with type 1 diabetes: Study design and baseline characteristics.

O’Donnell HK, Trojanowski PJ, Alonso GT, Majidi S, Snell-Bergeon J, Wadwa RP, Vigers T, Pyle L, Gurka MJ, Shaffer E, Driscoll KA.Contemp Clin Trials. 2023 Jun 20;131:107270. doi: 10.1016/j.cct.2023.107270. Online ahead of print.PMID: 37348599 13

Commentary: From Recommendations to Reality: Assessment and Treatment of Adolescents With Type 1 Diabetes and Disordered Eating Behaviors.

Wetter SE, Driscoll KA.J Pediatr Psychol. 2023 Jun 18:jsad036. doi: 10.1093/jpepsy/jsad036. Online ahead of print.PMID: 37330674No abstract available. 14

DHCR7 Expression Predicts Porsusor Outcomes and Mortality From Sepsis.

Guirgis FW, Jacob V, Wu D, Henson M, Daly-Crews K, Hopson C, Black LP, DeVos EL, Sulaiman D, Labilloy G, Brusko TM, Shavit JA, Bertrand A, Feldhammer M, Baskovich B, Graim K, Datta S, Reddy ST.Crit Care Explor. 2023 Jun 14;5(6):e0929. doi: 10.1097/CCE.0000000000000929. eCollection 2023 Jun.PMID: 37332366Free PMC article. 15

Proteome mapping of the human pancreatic islet microenvironment reveals endocrine-exocrine signaling sphere of influence.

Gosline SJ, Velickovic M, Pino J, Day LZ, Attah IK, Swensen AC, Danna V, Posso C, Rodland KD, Chen J, Matthews CE, Campbell-Thompson M, Laskin J, Burnum-Johnson K, Zhu Y, Piehowski PD.Mol Cell Proteomics. 2023 Jun 14:100592. doi: 10.1016/j.mcpro.2023.100592. Online ahead of print.PMID: 37328065Free article. 16

Measuring NAFLD models of care.

Allen AM, Younossi ZM, Tsochatzis EA, Alazawi W, Zelber-Sagi S, Arab JP, Cusi K, Lazarus JV.Nat Rev Gastroenterol Hepatol. 2023 Jun 8. doi: 10.1038/s41575-023-00798-9. Online ahead of print.PMID: 37291278No abstract available. 17

Immune engineered extracellular vesicles to modulate T cell activation in the context of type 1 diabetes.

Becker MW, Peters LD, Myint T, Smurlick D, Powell A, Brusko TM, Phelps EA.Sci Adv. 2023 Jun 2;9(22):eadg1082. doi: 10.1126/sciadv.adg1082. Epub 2023 Jun 2.PMID: 37267353Free article. 18

Diabetes and cirrhosis: Current concepts on diagnosis and management.

Castera L, Cusi K.Hepatology. 2023 Jun 1;77(6):2128-2146. doi: 10.1097/HEP.0000000000000263. Epub 2023 Jan 13.PMID: 36631005Review. 19

Modeling cell-mediated immunity in human type 1 diabetes by engineering autoreactive CD8⁺ T cells.

Peters LD, Yeh WI, Arnoletti JM, Brown ME, Posgai AL, Mathews CE, Brusko TM.Front Immunol. 2023 May 30;14:1142648. doi: 10.3389/fimmu.2023.1142648. eCollection 2023.PMID: 37325626Free PMC article. 20

A genomic data archive from the Network for Pancreatic Organ donors with Diabetes.

Perry DJ, Shapiro MR, Chamberlain SW, Kusmartseva I, Chamala S, Balzano-Nogueira L, Yang M, Brant JO, Brusko M, Williams MD, McGrail KM, McNichols J, Peters LD, Posgai AL, Kaddis JS, Mathews CE, Wasserfall CH, Webb-Robertson BM, Campbell-Thompson M, Schatz D, Evans-Molina C, Pugliese A, Concannon P, Anderson MS, German MS, Chamberlain CE, Atkinson MA, Brusko TM.Sci Data. 2023 May 26;10(1):323. doi: 10.1038/s41597-023-02244-6.PMID: 37237059Free PMC article. 21

Nutrient-dependent regulation of β-cell proinsulin content.

Xu X, Arunagiri A, Alam M, Haataja L, Evans CR, Zhao I, Castro-Gutierrez R, Russ HA, Demangel C, Qi L, Tsai B, Liu M, Arvan P.J Biol Chem. 2023 May 19;299(7):104836. doi: 10.1016/j.jbc.2023.104836. Online ahead of print.PMID: 37209827Free PMC article. 22

Ethnic Variations in Cardiovascular and Renal Outcomes From Newer Glucose-Lowering Drugs: A Meta-Analysis of Randomized Outcome Trials.

Tang H, Chen W, Bian J, O’Neal LJ, Lackland DT, Schatz DA, Guo J.J Am Heart Assoc. 2023 May 16;12(10):e026791. doi: 10.1161/JAHA.122.026791. Epub 2023 May 9.PMID: 37158069Free PMC article. 23

Suppression of local inflammation via galectin-anchored indoleamine 2,3-dioxygenase.

Bracho-Sanchez E, Rocha FG, Bedingfield SK, Partain BD, Macias SL, Brusko MA, Colazo JM, Fettis MM, Farhadi SA, Helm EY, Koenders K, Kwiatkowski AJ, Restuccia A, Morales BS, Wanchoo A, Avram D, Allen KD, Duvall CL, Wallet SM, Hudalla GA, Keselowsky BG.Nat Biomed Eng. 2023 May 1. doi: 10.1038/s41551-023-01025-1. Online ahead of print.PMID: 37127708 24

Research Priorities for Precision Medicine in NAFLD.

Iruzubieta P, Bataller R, Arias-Loste MT, Arrese M, Calleja JL, Castro-Narro G, Cusi K, Dillon JF, Martínez-Chantar ML, Mateo M, Pérez A, Rinella ME, Romero-Gómez M, Schattenberg JM, Zelber-Sagi S, Crespo J, Lazarus JV.Clin Liver Dis. 2023 May;27(2):535-551. doi: 10.1016/j.cld.2023.01.016. Epub 2023 Feb 26.PMID: 37024222Review. 25

Metabolic Syndrome and Its Association with Nonalcoholic Steatohepatitis.

Bril F, Sanyal A, Cusi K.Clin Liver Dis. 2023 May;27(2):187-210. doi: 10.1016/j.cld.2023.01.002. Epub 2023 Feb 26.PMID: 37024202Review. 26

Insulin thermostability in a real-world setting.

Pendsey S, James S, Garrett TJ, Nord AB, Pendsey S, Malmodin D, Karlsson G, Maniam J, Atkinson MA, Forsander G, Ogle GD.Lancet Diabetes Endocrinol. 2023 May;11(5):310-312. doi: 10.1016/S2213-8587(23)00028-1. Epub 2023 Mar 29.PMID: 37003280No abstract available. 27

Phenotypes Associated With Zones Defined by Area Under the Curve Glucose and C-peptide in a Population With Islet Autoantibodies.

Sosenko JM, Cuthbertson D, Sims EK, Ismail HM, Nathan BM, Jacobsen LM, Atkinson MA, Evans-Molina C, Herold KC, Skyler JS, Redondo MJ; TrialNet Study Group.Diabetes Care. 2023 May 1;46(5):1098-1105. doi: 10.2337/dc22-2236.PMID: 37000695 28

The ISPAD Clinical Practice Consensus Guidelines 2022: how far we have come and the distance still to go.

Bruggeman BS, Schatz DA.Lancet Diabetes Endocrinol. 2023 May;11(5):304-307. doi: 10.1016/S2213-8587(23)00083-9. Epub 2023 Mar 24.PMID: 36972713No abstract available. 29

Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial.

Russell WE, Bundy BN, Anderson MS, Cooney LA, Gitelman SE, Goland RS, Gottlieb PA, Greenbaum CJ, Haller MJ, Krischer JP, Libman IM, Linsley PS, Long SA, Lord SM, Moore DJ, Moore WV, Moran AM, Muir AB, Raskin P, Skyler JS, Wentworth JM, Wherrett DK, Wilson DM, Ziegler AG, Herold KC; Type 1 Diabetes TrialNet Study Group.Diabetes Care. 2023 May 1;46(5):1005-1013. doi: 10.2337/dc22-2200.PMID: 36920087Free PMC article.Clinical Trial. 30

Evaluation of PXL065 – deuterium-stabilized (R)-pioglitazone in patients with NASH: A phase II randomized placebo-controlled trial (DESTINY-1).

Harrison SA, Thang C, Bolze S, Dewitt S, Hallakou-Bozec S, Dubourg J, Bedossa P, Cusi K, Ratziu V, Grouin JM, Moller DE, Fouqueray P.J Hepatol. 2023 May;78(5):914-925. doi: 10.1016/j.jhep.2023.02.004. Epub 2023 Feb 18.PMID: 36804402Free article.Clinical Trial. 31

Disease progression joint model predicts time to type 1 diabetes onset: Optimizing future type 1 diabetes prevention studies.

Morales JF, Muse R, Podichetty JT, Burton J, David S, Lang P, Schmidt S, Romero K, O’Doherty I, Martin F, Campbell-Thompson M, Haller MJ, Atkinson MA, Kim S.CPT Pharmacometrics Syst Pharmacol. 2023 Apr 25. doi: 10.1002/psp4.12973. Online ahead of print.PMID: 37186151Free article. 32

A Reduced Pancreatic Polypeptide Response is Associated With New-onset Pancreatogenic Diabetes Versus Type 2 Diabetes.

Hart PA, Kudva YC, Yadav D, Andersen DK, Li Y, Toledo FGS, Wang F, Bellin MD, Bradley D, Brand RE, Cusi K, Fisher W, Mather K, Park WG, Saeed Z, Considine RV, Graham SC, Rinaudo JA, Serrano J, Goodarzi MO.J Clin Endocrinol Metab. 2023 Apr 13;108(5):e120-e128. doi: 10.1210/clinem/dgac670.PMID: 36404274Free PMC article. 33

Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients With Type 2 Diabetes and NAFLD.

Kalavalapalli S, Leiva EG, Lomonaco R, Chi X, Shrestha S, Dillard R, Budd J, Romero JP, Li C, Bril F, Samraj G, Pennington J, Townsend P, Orlando F, Shetty S, Mansour L, Silva-Sombra LR, Bedossa P, Malaty J, Barb D, Gurka MJ, Cusi K.J Clin Endocrinol Metab. 2023 Apr 13;108(5):1192-1201. doi: 10.1210/clinem/dgac660.PMID: 36378995 34

Generation of functional thymic organoids from human pluripotent stem cells.

Ramos SA, Armitage LH, Morton JJ, Alzofon N, Handler D, Kelly G, Homann D, Jimeno A, Russ HA.Stem Cell Reports. 2023 Apr 11;18(4):829-840. doi: 10.1016/j.stemcr.2023.02.013. Epub 2023 Mar 23.PMID: 36963390Free PMC article. 35

Single versus dual microgel species for forming guest-host microporous annealed particle PEG-MAL hydrogel.

Widener AE, Roberts A, Phelps EA.J Biomed Mater Res A. 2023 Apr 3. doi: 10.1002/jbm.a.37540. Online ahead of print.PMID: 37010360 36

Reducing Bias in Academic Publishing: The Diabetes Care Approach.

Kahn SE, Anderson CAM, Atkinson MA, Bakris GL, Buse JB, Hu FB, Rich SS, Riddle MC, Selvin E.Diabetes Care. 2023 Apr 1;46(4):665-666. doi: 10.2337/dci23-0014.PMID: 36952610No abstract available. 37

Integrated Physiology of the Exocrine and Endocrine Compartments in Pancreatic Diseases: Workshop Proceedings.

Mastracci TL, Apte M, Amundadottir LT, Alvarsson A, Artandi S, Bellin MD, Bernal-Mizrachi E, Caicedo A, Campbell-Thompson M, Cruz-Monserrate Z, El Ouaamari A, Gaulton KJ, Geisz A, Goodarzi MO, Hara M, Hull-Meichle RL, Kleger A, Klein AP, Kopp JL, Kulkarni RN, Muzumdar MD, Naren AP, Oakes SA, Olesen SS, Phelps EA, Powers AC, Stabler CL, Tirkes T, Whitcomb DC, Yadav D, Yong J, Zaghloul NA, Pandol SJ, Sander M.Diabetes. 2023 Apr 1;72(4):433-448. doi: 10.2337/db22-0942.PMID: 36940317 38

A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis.

Mak LY, Gane E, Schwabe C, Yoon KT, Heo J, Scott R, Lee JH, Lee JI, Kweon YO, Weltman M, Harrison SA, Neuschwander-Tetri BA, Cusi K, Loomba R, Given BD, Christianson DR, Garcia-Medel E, Yi M, Hamilton J, Yuen MF.J Hepatol. 2023 Apr;78(4):684-692. doi: 10.1016/j.jhep.2022.11.025. Epub 2022 Dec 10.PMID: 36513186Clinical Trial. 39

Pioglitazone discontinuation in patients with nonalcoholic steatohepatitis is associated with disease recurrence.

Bril F, Kalavalapalli S, Lomonaco R, Cusi K.Diabetes Obes Metab. 2023 Apr;25(4):1112-1116. doi: 10.1111/dom.14936. Epub 2022 Dec 22.PMID: 36495442No abstract available. 40

Engineering Modular, Oxygen-Generating Microbeads for the In Situ Mitigation of Cellular Hypoxia.

Accolla RP, Liang JP, Lansberry TR, Miravet IL, Loaisiga M, Sardi BL, Stabler CL.Adv Healthc Mater. 2023 Mar 27:e2300239. doi: 10.1002/adhm.202300239. Online ahead of print.PMID: 36971050 41

Validation of a Clinical Risk-based Classification System in a Large Nonalcoholic Fatty Liver Disease Real-world Cohort.

Sanyal AJ, Munoz B, Cusi K, Barritt AS 4th, Muthiah M, Mospan AR, Reddy KR, Firpi-Morell R, Thuluvath PJ, Bhamidimarri KR, Fried MW; TARGET-NASH Investigators.Clin Gastroenterol Hepatol. 2023 Mar 5:S1542-3565(23)00167-2. doi: 10.1016/j.cgh.2023.02.024. Online ahead of print.PMID: 36871772 42

Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice.

Phillip M, Nimri R, Bergenstal RM, Barnard-Kelly K, Danne T, Hovorka R, Kovatchev BP, Messer LH, Parkin CG, Ambler-Osborn L, Amiel SA, Bally L, Beck RW, Biester S, Biester T, Blanchette JE, Bosi E, Boughton CK, Breton MD, Brown SA, Buckingham BA, Cai A, Carlson AL, Castle JR, Choudhary P, Close KL, Cobelli C, Criego AB, Davis E, de Beaufort C, de Bock MI, DeSalvo DJ, DeVries JH, Dovc K, Doyle FJ, Ekhlaspour L, Shvalb NF, Forlenza GP, Gallen G, Garg SK, Gershenoff DC, Gonder-Frederick LA, Haidar A, Hartnell S, Heinemann L, Heller S, Hirsch IB, Hood KK, Isaacs D, Klonoff DC, Kordonouri O, Kowalski A, Laffel L, Lawton J, Lal RA, Leelarathna L, Maahs DM, Murphy HR, Nørgaard K, O’Neal D, Oser S, Oser T, Renard E, Riddell MC, Rodbard D, Russell SJ, Schatz DA, Shah VN, Sherr JL, Simonson GD, Wadwa RP, Ward C, Weinzimer SA, Wilmot EG, Battelino T.Endocr Rev. 2023 Mar 4;44(2):254-280. doi: 10.1210/endrev/bnac022.PMID: 36066457Free PMC article. 43

CGM Metrics Identify Dysglycemic States in Participants From the TrialNet Pathway to Prevention Study.

Wilson DM, Pietropaolo SL, Acevedo-Calado M, Huang S, Anyaiwe D, Scheinker D, Steck AK, Vasudevan MM, McKay SV, Sherr JL, Herold KC, Dunne JL, Greenbaum CJ, Lord SM, Haller MJ, Schatz DA, Atkinson MA, Nelson PW, Pietropaolo M; Type 1 Diabetes TrialNet Study Group.Diabetes Care. 2023 Mar 1;46(3):526-534. doi: 10.2337/dc22-1297.PMID: 36730530 44

Project ECHO Diabetes Cost Modeling to Support the Replication and Expansion of Tele-mentoring Programs in Non-research Settings.

Lewit EM, Figg LE, Addala A, Filipp SL, Lal R, Gurka MJ, Herndon JB, Haller MJ, Maahs DM, Walker AF; Project ECHO Diabetes Research Team.Diabetes Ther. 2023 Mar;14(3):509-518. doi: 10.1007/s13300-022-01364-3. Epub 2023 Jan 21.PMID: 36680682Free PMC article. 45

Time-Action Profile of Technosphere Insulin in Children with Type 1 Diabetes.

Haller MJ, Jones MC, Bhavsar S, Kaiserman KB.Diabetes Ther. 2023 Mar;14(3):611-617. doi: 10.1007/s13300-023-01368-7. Epub 2023 Jan 18.PMID: 36652106Free PMC article. 46

Expert Panel Consensus on Clinical Assertion Statements Describing Noninvasive Tools for Diagnosing Nonalcoholic Steatohepatitis.

Jacobson IM, Wong VW, Castera L, Anstee QM, Noureddin M, Cusi K, Harrison SA, Bugianesi E, Younossi ZM.J Clin Gastroenterol. 2023 Mar 1;57(3):253-264. doi: 10.1097/MCG.0000000000001780.PMID: 36251413Free PMC article. 47

Modeling the progression of Type 2 diabetes with underlying obesity.

Yang B, Li J, Haller MJ, Schatz DA, Rong L.PLoS Comput Biol. 2023 Feb 27;19(2):e1010914. doi: 10.1371/journal.pcbi.1010914. eCollection 2023 Feb.PMID: 36848379Free PMC article. 48

Cell Replacement Therapy for Type 1 Diabetes Patients: Potential Mechanisms Leading to Stem-Cell-Derived Pancreatic β-Cell Loss upon Transplant.

Shilleh AH, Russ HA.Cells. 2023 Feb 22;12(5):698. doi: 10.3390/cells12050698.PMID: 36899834Free PMC article.Review. 49

Divergent metabolic phenotypes in two genetic syndromes of low insulin secretion.

Guevara-Aguirre J, Rosenbloom AL, Guevara A, Atkinson MA, Williams MD, Terán E, Posgai AL, Guevara C, Rosado V, Gavilanes AWD, Wasserfall CH.Diabetes Res Clin Pract. 2023 Feb;196:110228. doi: 10.1016/j.diabres.2022.110228. Epub 2022 Dec 19.PMID: 36549505 50

A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis.

Younossi Z, Alkhouri N, Cusi K, Isaacs S, Kanwal F, Noureddin M, Loomba R, Ravendhran N, Lam B, Nader K, Racila A, Nader F, Henry L.Aliment Pharmacol Ther. 2023 Feb;57(3):304-312. doi: 10.1111/apt.17346. Epub 2022 Dec 13.PMID: 36511349 51

Biomaterials-based nanoparticles conjugated to regulatory T cells provide a modular system for localized delivery of pharmacotherapeutic agents.

Marshall GP, Cserny J, Wang CW, Looney B, Posgai AL, Bacher R, Keselowsky B, Brusko TM.J Biomed Mater Res A. 2023 Feb;111(2):185-197. doi: 10.1002/jbm.a.37442. Epub 2022 Sep 9.PMID: 36082558Free PMC article. 52

DHCR7 Expression Predicts Poor Outcomes and Mortality from Sepsis.

Guirgis FW, Jacob V, Wu D, Henson M, Daly-Crews K, Hopson C, Black LP, DeVos EL, Sulaiman D, Labilloy G, Brusko TM, Shavit JA, Bertrand A, Feldhammer M, Baskovich B, Graim K, Datta S, Reddy ST.Res Sq. 2023 Jan 30:rs.3.rs-2500497. doi: 10.21203/rs.3.rs-2500497/v1. Preprint.PMID: 36778468Free PMC article.Updated. 53

A streamlined tandem tip-based workflow for sensitive nanoscale phosphoproteomics.

Tsai CF, Wang YT, Hsu CC, Kitata RB, Chu RK, Velickovic M, Zhao R, Williams SM, Chrisler WB, Jorgensen ML, Moore RJ, Zhu Y, Rodland KD, Smith RD, Wasserfall CH, Shi T, Liu T.Commun Biol. 2023 Jan 18;6(1):70. doi: 10.1038/s42003-022-04400-x.PMID: 36653408Free PMC article. 54

Approach to the Patient With Nonalcoholic Fatty Liver Disease.

Belfort-DeAguiar R, Lomonaco R, Cusi K.J Clin Endocrinol Metab. 2023 Jan 17;108(2):483-495. doi: 10.1210/clinem/dgac624.PMID: 36305273 55

Abdominal obesity and dsyglycemia are risk factors for liver fibrosis progression in NAFLD subjects: A population-based study.

Julián MT, Ballesta S, Pera G, Pérez-Montes de Oca A, Soldevila B, Caballería L, Morillas R, Expósito C, Martínez-Escudé A, Puig-Domingo M, Franch-Nadal J, Torán P, Cusi K, Julve J, Mauricio D, Alonso N.Front Endocrinol (Lausanne). 2023 Jan 13;13:1051958. doi: 10.3389/fendo.2022.1051958. eCollection 2022.PMID: 36714592Free PMC article. 56

A multistakeholder approach to innovations in NAFLD care.

Schattenberg JM, Allen AM, Jarvis H, Zelber-Sagi S, Cusi K, Dillon JF, Caussy C, Francque SM, Younossi Z, Alkhouri N, Lazarus JV.Commun Med (Lond). 2023 Jan 3;3(1):1. doi: 10.1038/s43856-022-00228-y.PMID: 36596859Free PMC article. 57

Transcriptional Profile of Human Pancreatic Acinar Ductal Metaplasia.

Jiang J, Hakimjavadi H, Bray JK, Perkins C, Gosling A, daSilva L, Bulut G, Ali J, Setiawan VW, Campbell-Thompson M, Chamala S, Schmittgen TD.Gastro Hep Adv. 2023;2(4):532-543. doi: 10.1016/j.gastha.2023.02.003. Epub 2023 Feb 8.PMID: 37425649Free PMC article. 58

Functional Interrogation of Ca²⁺ Signals in Human Cancer Cells In Vitro and Ex Vivo by Fluorescent Microscopy and Molecular Tools.

Liang C, Huang M, Tanaka M, Lightsey S, Temples M, Lepler SE, Sheng P, Mann WP, Widener AE, Siemann DW, Sharma B, Xie M, Dai Y, Phelps E, Zeng B, Tang X.Methods Mol Biol. 2023;2679:95-125. doi: 10.1007/978-1-0716-3271-0_7.PMID: 37300611 59

Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practice.

Lazarus JV, Castera L, Mark HE, Allen AM, Adams LA, Anstee QM, Arrese M, Alqahtani SA, Bugianesi E, Colombo M, Cusi K, Hagström H, Loomba R, Romero-Gómez M, Schattenberg JM, Thiele M, Valenti L, Wong VW, Yilmaz Y, Younossi ZM, Francque SM, Tsochatzis EA.JHEP Rep. 2022 Sep 22;5(1):100596. doi: 10.1016/j.jhepr.2022.100596. eCollection 2023 Jan.PMID: 36644239Free PMC article. 60

Milder loss of insulin-containing islets in individuals with type 1 diabetes and type 2 diabetes-associated TCF7L2 genetic variants.

Redondo MJ, Richardson SJ, Perry D, Minard CG, Carr ALJ, Brusko T, Kusmartseva I, Pugliese A, Atkinson MA.Diabetologia. 2023 Jan;66(1):127-131. doi: 10.1007/s00125-022-05818-y. Epub 2022 Oct 25.PMID: 36282337Free PMC article. 61

Psychological Outcomes of the COVID-19 Pandemic on People with Type 1 Diabetes Globally: A Scoping Review.

Maizel JL, Dixon BN, Walker AF.Curr Diabetes Rev. 2023;19(5):115-132. doi: 10.2174/1573399818666220609154132.PMID: 35692128Review. 62

The progression of secondary diabetes: A review of modeling studies.

Yang B, Li J, Haller MJ, Schatz DA, Rong L.Front Endocrinol (Lausanne). 2022 Dec 21;13:1070979. doi: 10.3389/fendo.2022.1070979. eCollection 2022.PMID: 36619543Free PMC article.Review. 63

Tele-education model for primary care providers to advance diabetes equity: Findings from Project ECHO Diabetes.

Addala A, Filipp SL, Figg LE, Anez-Zabala C, Lal RA, Gurka MJ, Haller MJ, Maahs DM, Walker AF; Project ECHO Diabetes Research Team.Front Endocrinol (Lausanne). 2022 Dec 16;13:1066521. doi: 10.3389/fendo.2022.1066521. eCollection 2022.PMID: 36589850Free PMC article. 64

Tissue registration and exploration user interfaces in support of a human reference atlas.

Börner K, Bueckle A, Herr BW 2nd, Cross LE, Quardokus EM, Record EG, Ju Y, Silverstein JC, Browne KM, Jain S, Wasserfall CH, Jorgensen ML, Spraggins JM, Patterson NH, Weber GM.Commun Biol. 2022 Dec 13;5(1):1369. doi: 10.1038/s42003-022-03644-x.PMID: 36513738Free PMC article. 65

Understanding islet dysfunction in type 2 diabetes through multidimensional pancreatic phenotyping: The Human Pancreas Analysis Program.

Shapira SN, Naji A, Atkinson MA, Powers AC, Kaestner KH.Cell Metab. 2022 Dec 6;34(12):1906-1913. doi: 10.1016/j.cmet.2022.09.013. Epub 2022 Oct 6.PMID: 36206763Review. 66

Persistence of β-Cell Responsiveness for Over Two Years in Autoantibody-Positive Children With Marked Metabolic Impairment at Screening.

Sims EK, Cuthbertson D, Felton JL, Ismail HM, Nathan BM, Jacobsen LM, Paprocki E, Pugliese A, Palmer J, Atkinson M, Evans-Molina C, Skyler JS, Redondo MJ, Herold KC, Sosenko JM.Diabetes Care. 2022 Dec 1;45(12):2982-2990. doi: 10.2337/dc22-1362.PMID: 36326757 67

ISPAD Clinical Practice Consensus Guidelines 2022: Stages of type 1 diabetes in children and adolescents.

Besser REJ, Bell KJ, Couper JJ, Ziegler AG, Wherrett DK, Knip M, Speake C, Casteels K, Driscoll KA, Jacobsen L, Craig ME, Haller MJ.Pediatr Diabetes. 2022 Dec;23(8):1175-1187. doi: 10.1111/pedi.13410. Epub 2022 Sep 30.PMID: 36177823Review.No abstract available. 68

Incidence Trends of New-Onset Diabetes in Children and Adolescents Before and During the COVID-19 Pandemic: Findings From Florida.

Guo Y, Bian J, Chen A, Wang F, Posgai AL, Schatz DA, Shenkman EA, Atkinson MA.Diabetes. 2022 Dec 1;71(12):2702-2706. doi: 10.2337/db22-0549.PMID: 36094294 69

Type 1 diabetes knowledge assessment: The KAT-1 validation study.

Albanese-O’Neill A, MacInnes J, Haller MJ, Adams J, Thomas N, Bernier A.Pediatr Diabetes. 2022 Dec;23(8):1687-1694. doi: 10.1111/pedi.13414. Epub 2022 Oct 9.PMID: 36089647 70

HbA1c as a time predictive biomarker for an additional islet autoantibody and type 1 diabetes in seroconverted TEDDY children.

Salami F, Tamura R, You L, Lernmark Å, Larsson HE, Lundgren M, Krischer J, Ziegler AG, Toppari J, Veijola R, Rewers M, Haller MJ, Hagopian W, Akolkar B, Törn C; TEDDY Study Group.Pediatr Diabetes. 2022 Dec;23(8):1586-1593. doi: 10.1111/pedi.13413. Epub 2022 Sep 21.PMID: 36082496Free PMC article. 71

Clinical features, biochemistry, and HLA-DRB1 status in youth-onset type 1 diabetes in Mali.

Besançon S, Govender D, Sidibé AT, Noble JA, Togo A, Lane JA, Mack SJ, Atkinson MA, Wasserfall CH, Kakkat F, Martin GGN, Ogle GD.Pediatr Diabetes. 2022 Dec;23(8):1552-1559. doi: 10.1111/pedi.13411. Epub 2022 Sep 10.PMID: 36062396 72

Human stem cell derived beta-like cells engineered to present PD-L1 improve transplant survival in NOD mice carrying human HLA class I.

Santini-González J, Castro-Gutierrez R, Becker MW, Rancourt C, Russ HA, Phelps EA.Front Endocrinol (Lausanne). 2022 Nov 25;13:989815. doi: 10.3389/fendo.2022.989815. eCollection 2022.PMID: 36506044Free PMC article. 73

Commercially Available Insulin Products Demonstrate Consistency With Product Labeling Throughout All Seasons in the U.S.

Garrett TJ, Feizbakhsh Bazargani S, Harmon T, Kruse J, Atkinson P, Quinlivan EP, Ang L, Hirsch IB, Laffel L, Pietropaolo M, Haller MJ, Atkinson MA.Diabetes Care. 2022 Nov 1;45(11):e166-e168. doi: 10.2337/dc22-0972.PMID: 36102751No abstract available. 74

Management of NAFLD in primary care settings.

Wong VWS, Zelber-Sagi S, Cusi K, Carrieri P, Wright E, Crespo J, Lazarus JV.Liver Int. 2022 Nov;42(11):2377-2389. doi: 10.1111/liv.15404. Epub 2022 Sep 1.PMID: 35986897Review. 75

Accuracy of Three Commercial Home-Use Hemoglobin A1c Tests.

Jacobsen LM, Bocchino LE, Lum JW, Kollman C, Barnes-Lomen V, Sulik M, Haller MJ, Bode B, Cernich JT, Killeen AA, Garg U, Liljenquist D, Adams JG, Clements M, Gabrielson D, Johnson T, Clements MA, Beck RW.Diabetes Technol Ther. 2022 Nov;24(11):789-796. doi: 10.1089/dia.2022.0187.PMID: 35763337 76

The association of physical activity to oral glucose tolerance test outcomes in multiple autoantibody positive children: The TEDDY Study.

Johnson SB, Tamura R, McIver KL, Pate RR, Driscoll KA, Melin J, Larsson HE, Haller MJ, Yang J; TEDDY Study Group.Pediatr Diabetes. 2022 Nov;23(7):1017-1026. doi: 10.1111/pedi.13382. Epub 2022 Jun 24.PMID: 35702057 77

Exocrine and Endocrine Inflammation Increases Cellular Replication in the Pancreatic Duct Compartment in Type 1 Diabetes.

Kulkarni S, Posgai AL, Kusmartseva I, Wasserfall CH, Atkinson MA, Butler AE.J Endocr Soc. 2022 Sep 3;6(11):bvac136. doi: 10.1210/jendso/bvac136. eCollection 2022 Oct 11.PMID: 36249412Free PMC article. 78

Integrated Physiology of the Exocrine and Endocrine Compartments in Pancreatic Diseases: Workshop Proceedings.

Mastracci TL, Apte M, Amundadottir LT, Alvarsson A, Artandi S, Bellin MD, Bernal-Mizrachi E, Caicedo A, Campbell-Thompson M, Cruz-Monserrate Z, El Ouaamari A, Gaulton KJ, Geisz A, Goodarzi MO, Hara M, Hull-Meichle RL, Kleger A, Klein AP, Kopp JL, Kulkarni RN, Muzumdar MD, Naren AP, Oakes SA, Olesen SS, Phelps EA, Powers AC, Stabler CL, Tirkes T, Whitcomb DC, Yadav D, Yong J, Zaghloul NA, Sander M, Pandol SJ.Pancreas. 2022 Oct 1;51(9):1061-1073. doi: 10.1097/MPA.0000000000002170.PMID: 37078927Free PMC article. 79

COVID-19 Pandemic Effects on Caregivers of Youth With Type 1 Diabetes: Stress and Self-Efficacy.

Ismail HM, Hand BL, DiMeglio LA, Oyetoro R, Soni PY, Adams J, Westen S, Driscoll KA, Albanese-O’Neill A.Diabetes Spectr. 2022 Fall;35(4):461-468. doi: 10.2337/ds21-0092. Epub 2022 Mar 11.PMID: 36561657 80

Injectable Microporous Annealed Particle Hydrogel Based on Guest-Host-Interlinked Polyethylene Glycol Maleimide Microgels.

Widener AE, Duraivel S, Angelini TE, Phelps EA.Adv Nanobiomed Res. 2022 Oct;2(10):2200030. doi: 10.1002/anbr.202200030. Epub 2022 Aug 21.PMID: 36419640 81

Rising Hemoglobin A1c in the Nondiabetic Range Predicts Progression of Type 1 Diabetes As Well As Oral Glucose Tolerance Tests.

Vehik K, Boulware D, Killian M, Rewers M, McIndoe R, Toppari J, Lernmark Å, Akolkar B, Ziegler AG, Rodriguez H, Schatz DA, Krischer JP, Hagopian W; TEDDY Study Group.Diabetes Care. 2022 Oct 1;45(10):2342-2349. doi: 10.2337/dc22-0828.PMID: 36150054 82

Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles.

Martínez-Arranz I, Bruzzone C, Noureddin M, Gil-Redondo R, Mincholé I, Bizkarguenaga M, Arretxe E, Iruarrizaga-Lejarreta M, Fernández-Ramos D, Lopitz-Otsoa F, Mayo R, Embade N, Newberry E, Mittendorf B, Izquierdo-Sánchez L, Smid V, Arnold J, Iruzubieta P, Pérez Castaño Y, Krawczyk M, Marigorta UM, Morrison MC, Kleemann R, Martín-Duce A, Hayardeny L, Vitek L, Bruha R, Aller de la Fuente R, Crespo J, Romero-Gomez M, Banales JM, Arrese M, Cusi K, Bugianesi E, Klein S, Lu SC, Anstee QM, Millet O, Davidson NO, Alonso C, Mato JM.Hepatology. 2022 Oct;76(4):1121-1134. doi: 10.1002/hep.32427. Epub 2022 Mar 17.PMID: 35220605Free PMC article. 83

The role of GABA in islet function.

Hagan DW, Ferreira SM, Santos GJ, Phelps EA.Front Endocrinol (Lausanne). 2022 Sep 29;13:972115. doi: 10.3389/fendo.2022.972115. eCollection 2022.PMID: 36246925Free PMC article.Review. 84

Index60 Is Superior to HbA1c for Identifying Individuals at High Risk for Type 1 Diabetes.

Jacobsen LM, Bundy BN, Ismail HM, Clements M, Warnock M, Geyer S, Schatz DA, Sosenko JM.J Clin Endocrinol Metab. 2022 Sep 28;107(10):2784-2792. doi: 10.1210/clinem/dgac440.PMID: 35880956 85

Pharmacological inhibition and reversal of pancreatic acinar ductal metaplasia.

da Silva L, Jiang J, Perkins C, Atanasova KR, Bray JK, Bulut G, Azevedo-Pouly A, Campbell-Thompson M, Yang X, Hakimjavadi H, Chamala S, Ratnayake R, Gharaibeh RZ, Li C, Luesch H, Schmittgen TD.Cell Death Discov. 2022 Sep 2;8(1):378. doi: 10.1038/s41420-022-01165-4.PMID: 36055991Free PMC article. 86

Betel quid: New insights into an ancient addiction.

Stokes C, Pino JA, Hagan DW, Torres GE, Phelps EA, Horenstein NA, Papke RL.Addict Biol. 2022 Sep;27(5):e13223. doi: 10.1111/adb.13223.PMID: 36001424 87

Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study.

Ozonoff A, Schaenman J, Jayavelu ND, Milliren CE, Calfee CS, Cairns CB, Kraft M, Baden LR, Shaw AC, Krammer F, van Bakel H, Esserman DA, Liu S, Sesma AF, Simon V, Hafler DA, Montgomery RR, Kleinstein SH, Levy O, Bime C, Haddad EK, Erle DJ, Pulendran B, Nadeau KC, Davis MM, Hough CL, Messer WB, Higuita NIA, Metcalf JP, Atkinson MA, Brakenridge SC, Corry D, Kheradmand F, Ehrlich LIR, Melamed E, McComsey GA, Sekaly R, Diray-Arce J, Peters B, Augustine AD, Reed EF, Altman MC, Becker PM, Rouphael N; IMPACC study group members.EBioMedicine. 2022 Sep;83:104208. doi: 10.1016/j.ebiom.2022.104208. Epub 2022 Aug 8.PMID: 35952496Free PMC article. 88

Extracellular vesicles in β cell biology: Role of lipids in vesicle biogenesis, cargo, and intercellular signaling.

Aguirre RS, Kulkarni A, Becker MW, Lei X, Sarkar S, Ramanadham S, Phelps EA, Nakayasu ES, Sims EK, Mirmira RG.Mol Metab. 2022 Sep;63:101545. doi: 10.1016/j.molmet.2022.101545. Epub 2022 Jul 8.PMID: 35817393Free PMC article.Review. 89

A gut microbial peptide and molecular mimicry in the pathogenesis of type 1 diabetes.

Girdhar K, Huang Q, Chow IT, Vatanen T, Brady C, Raisingani A, Autissier P, Atkinson MA, Kwok WW, Kahn CR, Altindis E.Proc Natl Acad Sci U S A. 2022 Aug 2;119(31):e2120028119. doi: 10.1073/pnas.2120028119. Epub 2022 Jul 25.PMID: 35878027Free PMC article. 90

Hybrid Closed-Loop Systems and Glycemic Outcomes in Children and Adults With Type 1 Diabetes: Real-World Evidence From a U.S.-Based Multicenter Collaborative.

Noor N, Kamboj MK, Triolo T, Polsky S, McDonough RJ, Demeterco-Berggren C, Jacobsen L, Sonabend R, Ebekozien O, DeSalvo DJ.Diabetes Care. 2022 Aug 1;45(8):e118-e119. doi: 10.2337/dc22-0329.PMID: 35708494No abstract available. 91

Standard Operating Procedures for Biospecimen Collection, Processing, and Storage: From the Type 1 Diabetes in Acute Pancreatitis Consortium.

Wasserfall C, Dyer AM, Speake C, Andersen DK, Baab KT, Bellin MD, Broach JR, Campbell-Thompson M, Chinchilli VM, Lee PJ, Park WG, Pratley RE, Saloman JL, Sims EK, Tang G, Yadav D, Yazici C, Conwell DL; Type 1 Diabetes in Acute Pancreatitis Consortium (T1DAPC).Pancreas. 2022 Jul 1;51(6):593-597. doi: 10.1097/MPA.0000000000002077.PMID: 36206464Free PMC article. 92

Design and Rationale for the Use of Magnetic Resonance Imaging Biomarkers to Predict Diabetes After Acute Pancreatitis in the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study: From the Type 1 Diabetes in Acute Pancreatitis Consortium.

Tirkes T, Chinchilli VM, Bagci U, Parker JG, Zhao X, Dasyam AK, Feranec N, Grajo JR, Shah ZK, Poullos PD, Spilseth B, Zaheer A, Xie KL, Wachsman AM, Campbell-Thompson M, Conwell DL, Fogel EL, Forsmark CE, Hart PA, Pandol SJ, Park WG, Pratley RE, Yazici C, Laughlin MR, Andersen DK, Serrano J, Bellin MD, Yadav D; Type 1 Diabetes in Acute Pancreatitis Consortium (T1DAPC).Pancreas. 2022 Jul 1;51(6):586-592. doi: 10.1097/MPA.0000000000002080.PMID: 36206463Free PMC article. 93

Using Peer Power to Reduce Health Disparities: Implementation of a Diabetes Support Coach Program in Federally Qualified Health Centers.

Walker AF, Addala A, Sheehan E, Lal R, Haller M, Cuttriss N, Filipp S, Baer L, Gurka M, Bernier A, Figg L, Westen S, Hood K, Anez-Zabala C, Frank E, Roque X, Maizel J, Maahs D.Diabetes Spectr. 2022 Summer;35(3):295-303. doi: 10.2337/dsi22-0004. Epub 2022 Aug 15.PMID: 36082018Free PMC article. 94

Bring Blood Glucose Down! An intervention to reduce fear of hypoglycemia in caregivers of adolescents with type 1 diabetes: Study design and participant characteristics.

O’Donnell HK, Vigers T, Johnson SB, Pyle L, Gonder-Fredrick L, Hendrieckx C, Driscoll KA.Contemp Clin Trials. 2022 Jul;118:106792. doi: 10.1016/j.cct.2022.106792. Epub 2022 May 16.PMID: 35589025Clinical Trial. 95

Integrating Additive Manufacturing Techniques to Improve Cell-Based Implants for the Treatment of Type 1 Diabetes.

Accolla RP, Simmons AM, Stabler CL.Adv Healthc Mater. 2022 Jul;11(13):e2200243. doi: 10.1002/adhm.202200243. Epub 2022 Apr 22.PMID: 35412030Free PMC article.Review. 96

A Simple Test to Identify the Risk of NASH and Cirrhosis in People With Obesity or Diabetes: The Time to Screen Is Now.

Cusi K.J Clin Endocrinol Metab. 2022 Jun 16;107(7):e3076-e3077. doi: 10.1210/clinem/dgac186.PMID: 35333917Free PMC article.No abstract available. 97

Noninvasive Diagnosis of Nonalcoholic Steatohepatitis and Advanced Liver Fibrosis Using Machine Learning Methods: Comparative Study With Existing Quantitative Risk Scores.

Wu Y, Yang X, Morris HL, Gurka MJ, Shenkman EA, Cusi K, Bril F, Donahoo WT.JMIR Med Inform. 2022 Jun 6;10(6):e36997. doi: 10.2196/36997.PMID: 35666557Free PMC article. 98

α Cell dysfunction in islets from nondiabetic, glutamic acid decarboxylase autoantibody-positive individuals.

Doliba NM, Rozo AV, Roman J, Qin W, Traum D, Gao L, Liu J, Manduchi E, Liu C, Golson ML, Vahedi G, Naji A, Matschinsky FM, Atkinson MA, Powers AC, Brissova M, Kaestner KH, Stoffers DA; HPAP Consortium.J Clin Invest. 2022 Jun 1;132(11):e156243. doi: 10.1172/JCI156243.PMID: 35642629Free PMC article. 99

Greater ectopic fat deposition and liver fibroinflammation and lower skeletal muscle mass in people with type 2 diabetes.

Waddell T, Bagur A, Cunha D, Thomaides-Brears H, Banerjee R, Cuthbertson DJ, Brown E, Cusi K, Després JP, Brady M.Obesity (Silver Spring). 2022 Jun;30(6):1231-1238. doi: 10.1002/oby.23425. Epub 2022 Apr 27.PMID: 35475573Free PMC article. 100

Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial.

Gastaldelli A, Cusi K, Fernández Landó L, Bray R, Brouwers B, Rodríguez Á.Lancet Diabetes Endocrinol. 2022 Jun;10(6):393-406. doi: 10.1016/S2213-8587(22)00070-5. Epub 2022 Apr 22.PMID: 35468325Clinical Trial.